Thirdly, the preliminary data derived from the GO and KEGG analyses deciphered in part why SPINK1 could be a potential biomarker for the prediction of an immunologically hot tumor, which is possibly suitable for subsequent ICB therapy response in HCC (40). Here, SPINK1 is linked to neoplasm.